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Pain and Disability scales were used to quantify pain and disability. Catas-
trophizing was measured with the Pain Catastrophizing Scale. Repeated
measures general linear models were used to compare the patients in the
treatment group to a usual care cohort of 45 patients who also had received
knee arthroplasty and had high pain catastrophizing but no pain coping
skills training. Patient groups has comparable baseline characteristics.
Results: Compared to the usual care cohort, the patients who received pain
coping skills training reported signiﬁcantly greater and clinically important
reductions in pain severity and catastrophizing, and greater improvements
in function, two months after surgery (see table).
Conclusions: The ﬁndings provide preliminary evidence that the pain
coping skills treatment may be highly eﬃcacious for reducing pain, catas-
trophizing, and disability, in patients reporting elevated catastrophizing
prior to knee arthroplasty. A randomized clinical trial is warranted to
conﬁrm these effects.
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PERSISTENT KNEE PAIN AFTER A KNEE REPLACEMENT FOR
OSTEOARTHRITIS
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1Peninsula Med. Sch., Plymouth, United Kingdom; 2Nuﬃed Dept. of
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Purpose: Knee joint replacement is a successful, effective and cost effective
procedure for the treatment of osteoarthritis (OA). However, there are a
small number of patients who complain of persistent pain in the operated
joint, in spite of an apparently good technical outcome.
This study is a preliminary investigation into the causes of persistent pain
in the operated knee after technically successful medial uni-compartmental
knee joint replacement for antero-medial knee OA.
Methods: People with persistent knee pain of no known cause, and a
duration of 6 months or more after medial compartment UKR for OA,
were invited to attend a special clinic where a full history was taken, and
examination including quantitative sensory testing carried out. 21 subjects
agreed to attend.
Results: 18 of the 21 patients were women (compared with a F:M ratio of
1.1:1 for all UKRs done in the unit), their mean age was 58 (range 43-69)
and the mean interval since operation was 13 months (range 6 months to
3.5 years). Their current pain was described as severe by 10, moderate in
9 and mild in 1 case. 16 of the 21 subjects described the pain as quite
different in quality from the arthritis pain that they had experienced prior
to surgery, and 10 people described transient sharp attacks of spontaneous
pain in addition to their ‘usual’ more constant pain. On the basis of the
history and examination, patients were divided into three overlapping
groups:
1. Neuropathic pain: Sensory testing revealed allodynia in 10 cases, which
was severe in 7 and associated with a high score on ‘PainDetect’ question-
naires.
2. Mechanical pain: This group (n=7) complained of pain which was either
similar to that prior to surgery (5) and/or clearly associated with activity.
Examination suggested that the pain was coming from other compartments
of the knee, (e.g. patello-femoral joint), or from periarticular soft tissues.
3. Infero-medial bone pain: This group of another 7 patients complained of a
new sort of pain developing post-operatively, characterised by a dull ache
radiating down the medial side of the tibia, unrelated to activity.
In 5 cases there appeared to be a mixture of features, including aspects of
two or more of the above categories
Conclusions: Pain in OA joints with technically successful prostheses is
not uncommon and has a number of different causes. In the case of UKR,
a speciﬁc syndrome of antero-medial ‘bone’ pain can develop, in addition
to mechanical or neuropathic pain. These different types of pain can be
distinguished in clinic, and require different therapeutic approaches.
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THE IMPACT OF INVESTIGATIONAL SITE QUALITY TO PROVE EFFECTS ON
PAIN IN CLINICAL STUDIES OF OSTEOARTHRITIS OF THE KNEE
M. Rother1, S. Mazgareanu2, U. Vierl2, J. Vester3, I. Rother1
1X-pert Med GmbH, Graefelﬁng, Germany; 2IDEA AG, Munich, Germany; 3IDV,
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Purpose: Failure of large interventional, controlled studies in osteoarthritis
(OA) is not uncommon. If a study includes an internal control ("gold stan-
dard"), reasons other than failure of the experimental drug can be explored.
Poor study conduct at investigational sites is one of the reasons why a
study may fail. We explored and exempliﬁed the problem using two large
multicenter phase III studies with similar design and inclusion/exclusion
criteria investigating Diractin® (Ketoprofen Transfersome® Gel). Whereas
Study 1 showed statistically signiﬁcant results on pain, Study 2 failed to
conﬁrm those in the primary data analysis.
Methods: Study 1 was a multi-center, randomized, double-blind, multiple
dose, parallel group, placebo-controlled study investigating three different
dosages of ketoprofen in Diractin® in patients with OA of the knee (100
mg bid [n=223], 50 mg bid [n=223], 25 mg bid [n=221] and placebo
[n=199]) for a treatment period of 12 weeks. Study 2 was a multi-center,
randomized, double-blind, double-dummy, multiple dose, parallel group,
placebo- and active (naproxen)-controlled study investigating Diractin® in
the same dosages (100 mg bid [n = 164], 50 mg bid [n = 172], and 25 mg
bid [n = 175]), naproxen 500 mg bid [n = 164] and placebo [n = 162] for
12 weeks. Both studies used the VAS version of the WOMAC pain subscale
to evaluate effects on pain. Due to the high dropout rate of study 2 and
the weak response of the reference drug, the concept of “quality sites” was
introduced. A “quality site” was deﬁned by: 1) at least one patient per
treatment group received study medication, and 2) less than 50% major
protocol violations observed. The difference in study outcome for “quality”
and “non-quality sites” was evaluated using standard statistical methods
for the comparison of the placebo group to the naproxen group.
Results: In Study 1, 100 mg bid and 50 mg bid of ketoprofen in Diractin®
showed statistically signiﬁcant effects on pain (p = 0.0383 and p = 0.0204,
resp.). However, the primary analysis of Study 2 failed to show a statis-
tically signiﬁcant effect for Diractin®. The following differences between
Study 1 and Study 2 were observed with respect to study conduct.
Table 1. Key conduct features of the clinical studies
# Randomised # Per Protocol Patients Drop-out Screening failure
Patients/Site per Site Rate Rate
Study 1 28.0 21.0 17% 27%
Study 2 9.3 6.1 42% 92%
If the concept of “quality and non-quality sites” was introduced for Study
2, the statistical comparison of naproxen vs. placebo showed p = 0.0005 for
the “quality sites” as compared to p = 0.3679 for the “non-quality sites”.
Conclusions: Study conduct at the investigational site is crucial to detect
therapeutic effects on pain during interventional studies in OA of the knee.
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THE CHECK COHORT: PROGRESSIONOF PAIN OVER 2 YEARS OF PATIENTS
SUSPECTED OF HAVING EARLY OA
R.M. Rozendaal, J. Damen, M. Reijman, B.W. Koes, S.M. Bierma-Zeinstra
Erasmus Med. Ctr., Rotterdam, Netherlands
Purpose: The aim was to study the early progression of pain of patients
with both hip and knee complaints over 2 years. We planned on using three
different models in order to identify factors associated with progression of
pain and to assess what strategy we should use to investigate changes in
complaints due to (early) osteoarthritis.
Methods: A prospective cohort of 1002 participants with complaints of
knee and/or hip was formed between October ‘02 and September ‘05. The
participants will be followed for a period of at least 10 years.
Individuals were eligible to participate in the study if they had pain and/or
stiffness of knee and/or hip, were aged between 45 and 65 years, and
had never of or not longer than 6 months ago visited the GP for these
symptoms for the ﬁrst time. Exclusion criteria were any other pathological
condition that could explain the existing symptoms.
The primary outcome measures of this study were change in the Western
Ontario MacMaster questionnaire (WOMAC) pain subscale from baseline to
two years follow up.
Determinants were factors from the baseline assessment including: de-
mographic factors, factors relating to symptoms, co morbidities and
interventions, measurements from a physical examination, factors relating
to participation and lifestyle, radiographic assessments, and psychological
factors.
A univariate analysis was done on the 47 variables that were deemed
relevant. The variables that were related to the outcome (p<0.20) were
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then analysed per block. The ﬁnal model was made using the enter method
(p<0.05).
The data was analysed using 3 different approaches to deﬁne progression:
1) a change of more than 0.5 SD of the mean WOMAC pain score at
baseline, 2) a shift to a higher quintile-group, or remaining in the 3 highest
quintiles of WOMAC pain scores as proposed by Sharma et al., 3) any
deterioration in WOMAC pain score. The ﬁrst 2 approaches were analysed
with logistic regression analyses. The third approach was analysed with
linear regression analyses.
Results: Of the 1002 patients in the CHECK cohort, the majority were
female (79%). Mean age was 56 years. 82.7% of all patients had knee pain,
while 58.7% had hip pain at baseline. Almost half of the patients (41.4%)
consulted for hip and knee pain.
On average the pain of the CHECK patients declined slightly over the ﬁrst
two years. However, after two years 40.1% of the patients had a higher
WOMAC pain score than at baseline.
For the approach based on change >0.5 SD we found for hip complaints
that moderate alcohol use and a higher WOMAC pain score at baseline
protected against an increase, while a painful hip ﬂexion led to more
pain after two years. While the Sharma method only found a relation
between a painful hip ﬂexion and more pain. The linear regression analysis
yielded that having paid employment and more pain at baseline (WOMAC)
and a better health (SF 36) protected against more pain, while having
concomitant complaints of arm, neck and shoulder led to more pain.
For knee complaints the SD method yielded that moderate alcohol use,
more pain at baseline and a better vitality (SF 36) protected against an
increase in pain, while hip stiffness and a Kellgren & Lawrence (KL) score
of 2 or more was related to more pain after two years. Using the Sharma
method we found that moderate alcohol use and a better physical function-
ing score (SF 36) protected against more pain, while hip stiffness and a KL
≥ 2 led to more pain after two years. Finally the linear regression showed
that more pain at baseline (WOMAC) and a better physical functioning
score (SF 36) protected against an increase in pain.
Conclusions: We were able to identify several predictors on progression of
pain in early osteoarthritis. However the predictors for the 3 deﬁnitions of
deterioration of pain are very different. Not one factor was found in all 3
methods for one joint. This indicates that the choice of what is regarded as
deterioration is essential.
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NEUROMUSCULAR FUNCTION OF THE SCAPULAR STABILIZINGMUSCLES
WITH ANDWITHOUT ELECTROMYOGRAFICAL BIOFEEDBACK
C.M. Larsen1, A. Holtermann2, H.B. Olsen1, B. Juul-Kristensen1, K. Søgaard1
1Univ. of Southern Denmark, Inst. of Sports Sci. and Clinical Biomechanics,
Odense, Denmark; 2Natl. Res. Ctr. for the Working Enviroment, Copenhagen,
Denmark
Purpose: Subacromial impingement SI and glenohumeral osteoarthritis
(OA) are traditionally treated as separate pathologic conditions but often
present concurrently in the same patient and both conditions have been
associated with abnormal scapular positioning and muscle coordination.
A proposed impairment model could be that a lack of stabilizing activity
in the lower trapezius muscle could cause an alignment deviation of the
scapula. This could potentially lead to structural and pathomechanical
alterations like SI as a ﬁrst sign of increased deterioration in the joint even-
tually leading to OA. In the present study the aim was to compare subjects
with SI with healthy subjects regarding the neuromuscular function during
a standardized selective activation task subsequent to a visual biofeedback
guided training session.
Methods: Thirty subjects volunteered, 15 subjects with impingement syn-
drome (40 yrs ± 13) (imp) and 15 healthy subjects (39 yrs ± 12) (no-imp).
Inclusion criteria for imp were at least 30 days with pain/discomfort in the
shoulder/neck region within the last year and 2 or more positive impinge-
ment tests, while for no-imp it was less than 8 days with pain/discomfort
within the last year and no positive impingement tests.
Surface EMG was recorded from 4 parts of the trapezius muscle, maximal
EMG amplitude (MVE) was measured and muscle activity was calculated as
%MVE for each part. With subjects lying prone the EMG signals from the 4
parts of trapezius muscle were used for visual biofeedback source. Training
sessions of selective activation tasks of each of the 4 parts of trapezius
were conducted. Subsequently, the ﬁnal task was in 3 attempts of 30 sec
to perform the selective activation without visual biofeedback. Successful
selective activation was deﬁned as activity in the requested subdivision
above 12% while the others were below 1.5% MVE. Secondly, during the
attempt of selective activation the activation ratio was calculated as the
activity of the requested muscle part relative to the total activation in all 4
muscle parts in 1 sec time bins. For each task the largest 1 sec value was
taken as the peak value. An unpaired t-test was applied to test differences
between groups.
Results: A signiﬁcantly lower activation ratio for both the lower and upper
parts was found for both imp and no-imp when no visual guiding were
provided compared to the biofeedback training trials (table 1). Without
feedback no subjects were able to selectively activate the upper part but
5 no-imp vs. 0 imp subjects attained selective activation of the lower part.
Regarding activation ratio, there was no difference in the mean peak values
of imp and no-imp. However, 9 no-imp vs. 3 imp, attained an activation
ratio higher than 95% of the lower part while for the upper part none of
the subjects reached 95%.
Table 1. Number (%, SD) of subjects with (imp) and without Impingement (no-imp) who
are able to selectively activate trapezius muscles (upper/lower parts) during sessions
with and without visual biofeedback
Subjects N=30 Selective Selective Difference between
activation with activation without selective activation
biofeedback biofeedback with/without
(%, SD) (%, SD) biofeedback (p-value)
Imp. group 15
Lower subdivisons 95.6% (5.6) 90.5% (6.2) (p≤0.05)
Upper subdivisons 85.7% (14.9) 67.5% (14.9) (p≤0.001)
No-imp. group 15
Lower subdivisions 96.4% (2.8) 93.4% (4.4) (p≤0.05)
Upper subdivisions 85.3% (13.0) 70.2% (14.3) (p≤0.001)
Conclusions: The results indicate that the no-imp subjects after a biofeed-
back training session have a superior scapula muscle control compared to
the imp. The observed effect of biofeedback to increase activation ratio of
both upper and lower parts in attempted selective activation shows that it
is feasible to use biofeedback to improve the neuromuscular function and
thereby improve scapular coordination also in individuals with SI.
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HEALTH STATUS AND IMPACT OF PAIN: A COMPARATIVE STUDY
BETWEEN FEMALE PATIENTS WITH THE EHLERS-DANLOS SYNDROME,
FIBROMYALGIA AND RHEUMATOID ARTHRITIS
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Purpose: The Ehlers-Danlos Syndrome (EDS) is one the most prevalent
heritable connective tissue disorders. Generalized severe joint hypermo-
bility, which is frequently associated with joint dislocations, chronic pain
and premature osteoarthritis, is the dominant clinical manifestation of the
hypermobility subtype of EDS (EDS-HT). The musculoskeletal pain is early
in onset, chronic and debilitating. However, research on the burden of the
disease is scarce. The goal of this study was to compare the impact of
disease, assessed by measures of pain and health-related quality of life
(HRQOL), between patients with EDS-HT, ﬁbromyalgia (FM) and rheuma-
toid arthritis (RA), diseases which are characterized by chronic widespread
musculoskeletal pain.
Methods: A total of 206 female patients were compared: 72 patients
with EDS-HT, 69 patients with FM and 65 patients with RA. The psy-
chosocial impact of chronic pain was assessed using the Multidimensional
Pain Inventory (MPI), which comprises ﬁve subscales: pain severity, pain
interference, perceived life control, affective distress and social support.
The health-related dysfunction was quantiﬁed using the Sickness Impact
Proﬁle (SIP), containing twelve different subscales aggregated into a phys-
ical, psychosocial and overall health dimension. Scores were compared by
multivariate analysis of covariance, adjusting for age, years of education,
living status, and current statute. Bonferroni’s procedure was used to adjust
for multiple testing.
Results: The results of this study showed an important impact of pain
on everyday life for all groups (Figure 1). The MPI T-scores revealed
that the EDS-HT group has signiﬁcantly higher levels of pain intensity
